Cargando…
Acquired Inhibitors to Multiple Coagulation Factors (V, IX, and XII) Identified in a Unique Patient with Hepatocellular Carcinoma
An acquired formation of inhibitors to coagulation factors is a rare type of coagulopathy. The development of inhibitors for multiple coagulation factors has never been reported. A 75-year-old Japanese female underwent interventional therapy for hepatocellular carcinoma. Five days after the last int...
Autores principales: | Imataki, Osamu, Arai, Takeshi, Uemura, Makiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491817/ https://www.ncbi.nlm.nih.gov/pubmed/28502937 http://dx.doi.org/10.2169/internalmedicine.56.7845 |
Ejemplares similares
-
Potential clinical benefits of warfarin in end‐stage cancers: A retrospective analysis
por: Imataki, Osamu, et al.
Publicado: (2023) -
Fatal Rhabdomyolysis Caused by Morganella morganii in a Patient with Multiple Myeloma
por: Imataki, Osamu, et al.
Publicado: (2017) -
A class of carbonic anhydrase IX/XII – selective carboxylate inhibitors
por: Alhameed, Rakia Abd, et al.
Publicado: (2020) -
Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers
por: Williams, Kaye J., et al.
Publicado: (2019) -
Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
por: Onyılmaz, Mehmet, et al.
Publicado: (2022)